SAUD3.SA Bradsaude SA
- Market cap
- BRL 43.2B
- P/E
- 13.8x
- P/B
- 2.10x
- ROE
- 8.4%
- Dividend yield
- 1.53%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is SAUD3.SA undervalued?
Graham numberSAUD3.SA trades 13.5% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Bradsaude SA fundamental analysis
No fundamental analysis for Bradsaude SA yet.
Bradsaude SA stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Bradsaude SA
Bradsaúde S.A. provides private dental care plans in Brazil. The company operates through Corporate, Small and Medium-Sized Enterprise (SME), Individual, and Other segments. The company manages and sells dental care plans to corporations and/or individuals. It is also involved in commercial advisory, consulting, and business management services; develops and licenses software programs; wholesale and retail trade of products and equipment, sanitizers, drugs, medicines, pharma…
Full company profileBradsaude SA financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Bradsaude SA annual financial statements (BRL; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 1.37B | 1.44B | 1.59B | 1.81B | 1.77B | 1.85B | 1.85B | 2.12B | 2.28B | 2.42B | 17.4B |
| Gross Profit | 693M | 987M | 831M | 999M | 1.00B | 1.07B | 501M | 865M | 783M | 841M | 2.35B |
| Operating Income | 280M | -466M | 377M | 382M | 506M | 500M | 477M | 802M | 679M | 721M | 1.73B |
| EBITDA | 312M | 754M | 423M | 434M | 554M | 614M | 591M | 817M | 858M | 784M | 1.85B |
| Net Income | 216M | 503M | 285M | 285M | 361M | 380M | 366M | 511M | 539M | 583M | 1.58B |
| EPS | 0.37 | 0.85 | 0.49 | 0.49 | 0.62 | 0.72 | 0.66 | 0.93 | 0.99 | 1.07 | 0.54 |
| Balance Sheet | |||||||||||
| Total Assets | 1.35B | 1.39B | 1.65B | 1.77B | 1.92B | 1.93B | 1.87B | 2.16B | 2.12B | 1.95B | 41.7B |
| Total Liabilities | 654M | 463M | 616M | 652M | 714M | 813M | 744M | 776M | 894M | 667M | 23.0B |
| Shareholders' Equity | 694M | 923M | 1.03B | 1.11B | 1.20B | 1.12B | 1.13B | 1.39B | 1.23B | 1.28B | 18.7B |
| Cash & Short-term Investments | 428M | 436M | 482M | 544M | 737M | 332M | 231M | 372M | 374M | 293M | 13.2B |
| Total Debt | 590K | 47.0K | 358K | 40.7M | 33.7M | 42.8M | 20.4M | 30.9M | 25.8M | 20.8M | 205M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 196M | 289M | 324M | 309M | 305M | 858M | 695M | 415M | 605M | 596M | 529M |
| Capital Expenditure | 13.5M | 13.9M | 21.9M | 32.8M | 25.3M | 46.5M | 63.0M | 95.3M | 92.5M | 6.25M | 14.7M |
| Free Cash Flow | 183M | 276M | 302M | 276M | 280M | 812M | 632M | 319M | 512M | 590M | 515M |
| Ratios | |||||||||||
| ROE | 31.1% | 54.5% | 27.7% | 25.6% | 30.0% | 34.1% | 32.4% | 36.9% | 43.9% | 45.4% | 8.4% |
| ROA | 16.0% | 36.2% | 17.3% | 16.1% | 18.8% | 19.7% | 19.5% | 23.6% | 25.4% | 29.9% | 3.8% |
| Net Profit Margin | 15.8% | 35.0% | 17.9% | 15.7% | 20.5% | 20.6% | 19.7% | 24.1% | 23.6% | 24.1% | 9.1% |
| Debt to Equity | 0.00x | 0.00x | 0.00x | 0.04x | 0.03x | 0.04x | 0.02x | 0.02x | 0.02x | 0.02x | 0.01x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Bradsaude SA dividends
- Dividend yield
- 1.53%
- Forward dividend
- 0.75 BRL
- Payout ratio
- 113.7%
- Ex-dividend date
- Nov 3, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | BRL 662M | 1.21 | 113.7% |
| 2024 | BRL 543M | 0.99 | 100.7% |
| 2023 | BRL 183M | 0.33 | 35.8% |
| 2022 | BRL 170M | 0.31 | 46.4% |
| 2021 | 261M | 0.50 | 68.7% |
| 2020 | 270M | 0.46 | 74.8% |
| 2019 | 251M | 0.43 | 88.1% |
| 2018 | 86.8M | 0.15 | 30.5% |
| 2017 | 279M | 0.47 | 55.6% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 11:10 on Apr 5, 2022.
Who owns Bradsaude SA
- Insiders 53.54%
- Institutions 24.08%
- Public & others 22.39%
- Shares outstanding 2.92B
- Free float 253M
Bradsaude SA company profile
- Company name
- Bradsaude SA
- Ticker
- SAUD3.SA
- Exchange
- Sao Paulo Exchange
- Sector
- Healthcare
- Industry
- Healthcare Plans
- Employees
- 1,957
- Fiscal year end
- December
- Address
- Alameda Araguaia, 2104, Barueri, SP, Brazil, 06455-000
- Phone
- 55 80 0702 9000
About Bradsaude SA
Bradsaúde S.A. provides private dental care plans in Brazil. The company operates through Corporate, Small and Medium-Sized Enterprise (SME), Individual, and Other segments. The company manages and sells dental care plans to corporations and/or individuals. It is also involved in commercial advisory, consulting, and business management services; develops and licenses software programs; wholesale and retail trade of products and equipment, sanitizers, drugs, medicines, pharmaceutical inputs, and related items; provision of storage, loading, organization, tidying, custody of goods, technical, and administrative programming services, as well as general management of assets and business. In addition, the company engages in integrating technologies to develop dental solutions; and provide specialized services related to accidents and illnesses, besides actuarial, financial, administrative, and commercial and risk management services. The company was formerly known as Odontoprev S.A. and changed its name to Bradsaúde S.A. in April 2026. Bradsaúde S.A. was founded in 1987 and is headquartered in Barueri, Brazil. Bradsaúde S.A. operates as a subsidiary of Bradesco Saúde S.A.
Bradsaude SA management
6- Mr. Carlos Alberto Iwata MarinelliChief Executive Officer · born 1977
- Mr. Vinicius Marinho da CruzChief Financial Officer
- Mr. José Roberto Borges PachecoDirector of Investor Relations · born 1961
- Ms. Rose GabayHuman Resources Director · born 1963
- Catarina BrunoIR & Treasury Supervisor
- Ms. Stella HongIR Supervisor